Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06526858 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT06526858 · ClinicalTrials.gov record · last posted 2026-08-10

Early Feasibility Study of "HyperQureTM RDN System", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension

Name: Early Feasibility Study of "HyperQureTM RDN System", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension — clinical trial record (NCT06526858)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhaseNot applicable

SponsorDeepQure Inc.

Started2024-11-21

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

HQ-HTN-G01 is a prospective, multicenter, single arm, open label, early feasibility study to evaluate initial safety and device design concept of "HyperQureTM RDN System", laparoscopic renal denervation therapy, in patients with resistant hypertension on three(3) or more antihypertensive medications

Protocol amendment history 2 changes detected by DataLookout

2026-08-11

Primary completion pushed: 2026-06-18 → 2027-03-31

2026-08-11

Completion pushed: 2029-03-20 → 2029-12-31

Trial Details

NCT Number	NCT06526858
Lead Sponsor	DeepQure Inc.
Conditions	Resistant Hypertension
Enrollment	15 participants
Start Date	2024-11-21
Primary Completion	2027-03-31 (estimated)
Study Completion	2029-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-08-10